FY2024 PBT rebounded to RM 109.9M (+166% YoY) on the Kaiserkorp divestment and disciplined cost reset, while revenue moderated to RM 1.09B as CBB rationalised its packaging footprint.
Group revenue moved from RM 1.08B in FY2020 to a peak of RM 1.36B in FY2022, then eased to RM 1.09B in FY2024 as CBB restructured carton and offset capacity. PATAMI swung from RM 8.9M in FY2023 to RM 73.1M in FY2024 (EPS 13.61 sen) — a clean turnaround driven by Toyoplas, CPI and MDS Advance operational discipline plus the RM 56M gain on Kaiserkorp divestment.
Gearing dropped from 0.6x in FY2020 to 0.2x post-Sukuk repayment, with cash of RM 385.6M giving headroom for selective acquisitions. The portfolio now spans 15 manufacturing facilities across Malaysia, China, Vietnam and Indonesia, serving consumer electronics, EMS, healthcare, semiconductors, packaging and water chemicals customers.